"Многопрофильный медицинский центр"

During the past decade, Private Medical Institution "Euromedservice" conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Private Medical Institution "Euromedservice"" #1 sponsor was "Pfizer" with 9 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Geropharm" with 3 trials sponsored, "BeiGene" with 2 trials sponsored and "Materia Medica Holding" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Private Medical Institution "Euromedservice"" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Bayer AG (Sponsor)" with 1 trials as a collaborator and "Bracco (Sponsor)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Private Medical Institution "Euromedservice"" are "Influenza" (3 trials), "Varicose Veins of Lower Limb" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Diabetes Mellitus" (2 trials) and "Diabetes Mellitus, Type 1" (2 trials). Many other conditions were trialed in "Private Medical Institution "Euromedservice"" in a lesser frequency.

Most popular intervention types in "Private Medical Institution "Euromedservice"" are "Drug" (28 trials), "Biological" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Pembrolizumab" (3 trials), "Cisplatin" (2 trials), "Docetaxel" (2 trials) and "Encorafenib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Private Medical Institution "Euromedservice"" are 29 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Private Medical Institution "Euromedservice"". undefined are not yet recruiting, 14 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Private Medical Institution "Euromedservice", undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Private Medical Institution "Euromedservice", 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".